Volume 24, Issue 5 pp. e312-e321
ORIGINAL ARTICLE

Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment

H. H. Pitkänen

H. H. Pitkänen

Helsinki University Hospital Research Institute, Helsinki, Finland

Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for more papers by this author
M. Kärki

M. Kärki

Department of Pediatrics, University of Turku, Turku, Finland

Search for more papers by this author
H. Niinikoski

H. Niinikoski

Department of Pediatrics and Physiology, University of Turku, Turku, Finland

Search for more papers by this author
L. Tanner

L. Tanner

Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland

Department of Clinical Genetics, Turku University Hospital, Turku, Finland

Search for more papers by this author
K. Näntö-Salonen

K. Näntö-Salonen

Department of Pediatrics, University of Turku, Turku, Finland

Search for more papers by this author
M. Pikta

M. Pikta

Northern Estonian Medical Center, Tallin, Estonia

Search for more papers by this author
W. F. Kopatz

W. F. Kopatz

Department of Experimental Vascular Medicine, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Search for more papers by this author
M. Zuurveld

M. Zuurveld

Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands

Search for more papers by this author
J. C. M. Meijers

J. C. M. Meijers

Department of Experimental Vascular Medicine, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands

Search for more papers by this author
H. J. M. Brinkman

H. J. M. Brinkman

Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands

Search for more papers by this author
R. Lassila

Corresponding Author

R. Lassila

Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Laboratory Services HUSLAB, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Correspondence

Riitta Lassila, Coagulation Disorders Unit, Department of Hematology and Comprehensive Cancer Center, Laboratory Services, Helsinki University Hospital, Helsinki, Finland.

Email: [email protected]

Search for more papers by this author
First published: 02 August 2018
Citations: 16

Funding information

Funding was received from Helsinki University Governmental Grant, The Finnish Society of Anaesthesiologists, Finnish Hematology Association, and Blood Disease Research Foundation.

Pitkänen and Kärki equally contributed to this study.

Abstract

Introduction

Lysinuric protein intolerance (LPI), a rare autosomal recessive transport disorder of cationic amino acids lysine, arginine and ornithine, affects intestines, lungs, liver and kidneys. LPI patients may display potentially life-threatening bleeding events, which are poorly understood.

Aims

To characterize alterations in haemostatic and fibrinolytic variables associated with LPI.

Methods

We enrolled 15 adult patients (8 female) and assessed the clinical ISTH/SSC-BAT bleeding score (BS). A variety of metabolic and coagulation assays, including fibrin generation test derivatives, clotting time (CT) and clot lysis time (CLT), thromboelastometry (ROTEM), and PFA-100 and Calibrated Automated Thrombogram (CAT), were used.

Results

All patients had mild-to-moderate renal insufficiency, and moderate bleeding tendency (BS 4) without spontaneous bleeds. Mild anaemia and thrombocytopenia occurred. Traditional clotting times were normal, but in contrast, CT in fibrin generation test, and especially ROTEM FIBTEM was abnormal. The patients showed impaired primary haemostasis in PFA, irrespective of normal von Willebrand factor activity, but together with lowered fibrinogen and FXIII. Thrombin generation (TG) was reduced in vitro, according to CAT-derived endogenous thrombin potential, but in vivo TG was enhanced in the form of circulating prothrombin fragment 1 and 2 values. Very high D-dimer and plasmin-α2-antiplasmin (PAP) complex levels coincided with shortened CLT in vitro.

Conclusions

Defective primary haemostasis, coagulopathy, fibrin abnormality (FIBTEM, CT and CLT), low TG in vitro and clearly augmented fibrinolysis (PAP and D-dimer) in vivo were all detected in LPI. Altered fibrin generation and hyperfibrinolysis were associated with the metabolic and renal defect, suggesting a pathogenetic link in LPI.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.